My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 537

    1.

    Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

    Avignon A, Sultan A, Piot C, Elaerts S, Cristol JP, Dupuy AM.

    Diabetes Care. 2005 Sep;28(9):2176-80.PMID: 16123486 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.

    Anand DV, Lahiri A, Lim E, Hopkins D, Corder R.

    J Am Coll Cardiol. 2006 May 2;47(9):1850-7. Epub 2006 Apr 19.PMID: 16682312 [PubMed - indexed for MEDLINE]Related articles

    3.

    Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients.

    Avignon A, Sultan A, Piot C, Mariano-Goulart D, Thuan Dit Dieudonné JF, Cristol JP, Dupuy AM.

    Diabetes Care. 2007 Nov;30(11):2934-9. Epub 2007 Aug 21.PMID: 17712025 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism.

    Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P.

    Diabetes Care. 2002 Aug;25(8):1418-24.PMID: 12145244 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.

    Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH, Shen WF.

    Cardiovasc Diabetol. 2006 Dec 20;5:27.PMID: 17178005 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction.

    Crisafulli A, Micari A, Altavilla D, Saporito F, Sardella A, Passaniti M, Raffa S, D'anneo G, Lucà F, Mioni C, Arrigo F, Squadrito F.

    Clin Sci (Lond). 2005 Oct;109(4):389-95.PMID: 15926884 [PubMed - indexed for MEDLINE]Related articles

    7.

    Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.

    Gannagé-Yared MH, Fares F, Semaan M, Khalife S, Jambart S.

    Clin Endocrinol (Oxf). 2006 Jun;64(6):652-8.PMID: 16712667 [PubMed - indexed for MEDLINE]Related articles

    8.

    Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications.

    Knudsen ST, Foss CH, Poulsen PL, Andersen NH, Mogensen CE, Rasmussen LM.

    Eur J Endocrinol. 2003 Jul;149(1):39-42. Erratum in: Eur J Endocrinol. 2003 Aug;149(2):161. PMID: 12824864 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease.

    Matsumoto K, Kizaki Y, Fukae S, Tomihira M, Sera Y, Ueki Y, Tominaga T, Miyake S.

    Diabetes Res Clin Pract. 2001 Mar;51(3):181-6.PMID: 11269890 [PubMed - indexed for MEDLINE]Related articles

    10.

    Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.

    Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A.

    J Am Coll Cardiol. 2006 Jan 3;47(1):65-71. Epub 2005 Dec 9.PMID: 16386666 [PubMed - indexed for MEDLINE]Related articles

    11.

    Silent myocardial ischemia in patients with diabetes: who to screen.

    Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V.

    Diabetes Care. 1999 Sep;22(9):1396-400.PMID: 10480499 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity.

    Kim SM, Lee J, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM.

    Clin Endocrinol (Oxf). 2005 Nov;63(5):594-8.PMID: 16268814 [PubMed - indexed for MEDLINE]Related articles

    13.

    Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease.

    Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y.

    Circulation. 2002 Sep 3;106(10):1192-4.PMID: 12208791 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Increased osteoprotegerin serum levels in men with coronary artery disease.

    Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC.

    J Clin Endocrinol Metab. 2003 Mar;88(3):1024-8.PMID: 12629080 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients.

    Bacci S, Menzaghi C, Ercolino T, Ma X, Rauseo A, Salvemini L, Vigna C, Fanelli R, Di Mario U, Doria A, Trischitta V.

    Diabetes Care. 2004 Aug;27(8):2015-20.PMID: 15277433 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Coronary artery disease in asymptomatic type-2 diabetic women. A comparative study between exercise test, cardiopulmonary exercise test, and dipyridamole myocardial perfusion scintigraphy in the identification of ischemia.

    Smanio PE, Carvalho AC, Tebexreni AS, Thom A, Rodrigues F, Meneghelo R, Mastrocolla L, Alves A, Piegas LS, Paola AA.

    Arq Bras Cardiol. 2007 Nov;89(5):263-9, 290-7. English, Portuguese. PMID: 18066448 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.

    Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Yoshida T, Sato A, Imaizumi T.

    Diabetes Metab Res Rev. 2007 Jul;23(5):368-71.PMID: 17024691 [PubMed - indexed for MEDLINE]Related articles

    18.

    Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein.

    Rhee EJ, Lee WY, Kim SY, Kim BJ, Sung KC, Kim BS, Kang JH, Oh KW, Oh ES, Baek KH, Kang MI, Woo HY, Park HS, Kim SW, Lee MH, Park JR.

    Clin Sci (Lond). 2005 Mar;108(3):237-43.PMID: 15569000 [PubMed - indexed for MEDLINE]Related articles

    19.

    Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status.

    Galluzzi F, Stagi S, Salti R, Toni S, Piscitelli E, Simonini G, Falcini F, Chiarelli F.

    Eur J Endocrinol. 2005 Dec;153(6):879-85.PMID: 16322394 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.

    Anand DV, Lim E, Darko D, Bassett P, Hopkins D, Lipkin D, Corder R, Lahiri A.

    J Am Coll Cardiol. 2007 Dec 4;50(23):2218-25. Epub 2007 Nov 19.PMID: 18061069 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity